Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNichols plc Regulatory News (NICL)

Share Price Information for Nichols plc (NICL)

Share Price is delayed by 15 minutes
Get Live Data
942.00    4.00 (0.43%)
Bid:
934.00
Ask:
952.00
Spread: 18.00 (1.927%)
Market Cap: £344.43m
NICL Live PriceLast checked at - London Stock Exchange

Intraday Nichols plc Share Chart

Directorate Change

7 Mar 2013 07:00

RNS Number : 4275Z
Nichols PLC
07 March 2013
 



 

 

Date:

Embargoed until 07.00am, Thursday 07 March 2013

 

Contacts:

John Nichols, Non-Executive Chairman

Brendan Hynes, Group Chief Executive

Tim Croston, Group Finance Director

Nichols plc

Telephone: 01925 222222

Website:www.nicholsplc.co.uk

 

 

Nichols plc

 

Directorate Change

 

After 10 successful years with Nichols plc, Brendan Hynes, Chief Executive Officer, has informed the Board of his intention to step down in order to pursue a non-executive portfolio career. He will continue in his role full time until the AGM on 1 May 2013 and will be available to help and support the business with the handover until the end of 2013.

 

Marnie Millard will be appointed Chief Executive Officer with effect from 1 May 2013. Marnie is currently Managing Director of our Vimto Soft Drinks UK business and has more than 17 years experience in the soft drinks industry. Previously, she has held senior roles at Gerber Juice Company Ltd, Refresco Ltd and Macaw Soft Drinks Ltd.

 

 

 

Comments on the Directorate change

 

John Nichols, Non-Executive Chairman said: "Brendan has been instrumental in the transformation of the Nichols Group into an international, highly successful, branded soft drinks business. I would like to thank him for his outstanding contribution to the development and growth of our business during the last 10 years and wish him every success as he moves into a new phase in his career.

 

I am delighted that Marnie Millard, who is a valued and highly respected member of our executive team, will succeed Brendan. Marnie's deep understanding of the soft drinks industry, combined with her leadership skills, energy and enthusiasm means that she is well positioned to drive our continued success, while ensuring a seamless transition."

 

Brendan Hynes, Group Chief Executive said: "After ten happy years with the Nichols group, I have taken the difficult decision to leave a highly successful business and move onto the next stage of my career. The business has changed beyond all recognition over the last ten years and it has been a real pleasure to have worked with a great team and great brands and to have played a key part in building the strong, globally successful business that we are today."

 

 

AIM Rules disclosures

 

Marnie-Jane Millard (previously known as Marnie-Jane Mumby and nee Tabbitt), aged 48, holds no shares in the Company. Other than as set out below there is no further information to be disclosed under schedule 2(g) and Rule 17 of the AIM Rules in respect of Mrs Millard's appointment as a Director of the Company.

 

Current Directorships

Past Directorships in the last 5 years

THE BRITISH SOFT DRINKS ASSOCIATION LIMITED

CONNECT WETHERBY LIMITED

REFRESCO LIMITED

 

 

End

 

 

 

 

Enquiries:

 

 

 

 

Alex Brennan/ Nick Lyon

 

 

Richard Lindley / Jonny Franklin-Adams

Hudson Sandler

N+1 Singer (Nominated Adviser)

Telephone:020 7796 4133

Telephone: 0207 496 3000

Email: nichols@hspr.com

Website: www.n1singer.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAEAPDKEAKDEFF
Date   Source Headline
6th Apr 20215:48 pmRNSHolding(s) in Company
22nd Mar 20211:00 pmRNSPublication of Annual Report and Notice of AGM
8th Mar 20214:41 pmRNSSecond Price Monitoring Extn
8th Mar 20214:35 pmRNSPrice Monitoring Extension
8th Mar 202112:57 pmRNSDirector/PDMR Shareholding
5th Mar 20214:45 pmRNSDirector/PDMR Shareholding
4th Mar 20214:17 pmRNSDirector/PDMR Shareholding
3rd Mar 20217:00 amRNS2020 Preliminary Result
1st Feb 20214:40 pmRNSSecond Price Monitoring Extn
1st Feb 20214:35 pmRNSPrice Monitoring Extension
12th Jan 20217:00 amRNSTrading Update
21st Dec 20204:40 pmRNSSecond Price Monitoring Extn
21st Dec 20204:35 pmRNSPrice Monitoring Extension
21st Dec 20207:00 amRNSDirector Share Awards
3rd Dec 20204:36 pmRNSPrice Monitoring Extension
1st Dec 20209:45 amRNSPDMR Dealing & Director’s Interest
27th Nov 20204:42 pmRNSSecond Price Monitoring Extn
27th Nov 20204:38 pmRNSPrice Monitoring Extension
19th Nov 20207:00 amRNSTrading Update
16th Nov 20204:41 pmRNSSecond Price Monitoring Extn
16th Nov 20204:36 pmRNSPrice Monitoring Extension
11th Nov 20204:40 pmRNSSecond Price Monitoring Extn
11th Nov 20204:35 pmRNSPrice Monitoring Extension
30th Sep 20201:22 pmRNSDirector/PDMR Shareholding
22nd Jul 20207:01 amRNSDirectorate Change and Relationship Agreement
22nd Jul 20207:00 amRNS2020 Interim Results & Board Changes
3rd Jul 202012:07 pmRNSSecond Price Monitoring Extn
3rd Jul 202012:02 pmRNSPrice Monitoring Extension
24th Jun 202012:07 pmRNSSecond Price Monitoring Extn
24th Jun 202012:02 pmRNSPrice Monitoring Extension
11th Jun 20207:00 amRNSGrant of SAYE Options and PDMR Dealings
8th Jun 20204:40 pmRNSSecond Price Monitoring Extn
8th Jun 20204:36 pmRNSPrice Monitoring Extension
8th Jun 202012:02 pmRNSPrice Monitoring Extension
6th May 202010:07 amRNSDirector/PDMR Shareholding
29th Apr 20204:35 pmRNSPrice Monitoring Extension
29th Apr 202011:33 amRNSResult of AGM
29th Apr 202011:11 amRNSPDMR/PCA Dealing
17th Apr 20204:42 pmRNSSecond Price Monitoring Extn
17th Apr 20204:36 pmRNSPrice Monitoring Extension
15th Apr 202012:02 pmRNSPrice Monitoring Extension
8th Apr 20207:00 amRNSAGM
31st Mar 20207:00 amRNSCOVID-19 Trading Update
18th Mar 20204:41 pmRNSSecond Price Monitoring Extn
18th Mar 20204:38 pmRNSPrice Monitoring Extension
26th Feb 20207:00 amRNSPreliminary Results
10th Jan 20204:34 pmRNSHolding(s) in Company
9th Jan 20207:00 amRNS2019 Trading Update
23rd Dec 20197:00 amRNSTrading update
9th Dec 20193:24 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.